Report : Asia Pacific Bioreactors Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User [Research and development organizations, Biopharma Manufacturers, and Contract Manufacturing Organizations (CMOs)] and Country
Mammalian Cells Segment Held Largest Share of Asia Pacific Market in 2019
According to our new market research study on “Asia Pacific Bioreactors Marketto 2027 – Regional Analysis and Forecast – by Cell, Molecule, Technology,and End User,” the market is expected to reach US$ 994.52 Mn by 2027 from US$ 544.51 Mn in 2019; it is estimated to grow at a CAGR of 7.9% during 2020–2027.The report provides trends prevailing in the Asia Pacificbioreactors market and the factors driving market growth along with those restraining it.
The Asia Pacificbioreactors market, based on the cell, is segmented into mammalian cells, bacterial cells, yeast cells,and others.The mammalian cellsegment held the largest share of the market in 2019, and the yeast cell segment estimated to register the highest CAGR during the forecast period. The projected growth of the yeast cells segment is attributed to the increased use of these cells as a single culture, or along with other probiotic strains, in probiotic production. Moreover, mounting research activities related to the industrial-scale production of probiotic yeasts would boost the growth of the market for this segment in the coming years.
The growth of the Asia Pacific bioreactors market is mainly attributed to the increasing adoption of single-use bioreactors, and rapidly growing demand for bioreactors from biopharmaceutical and biotechnology industries. However, stringent regulatory framework is the major factor hindering the market growth in this region.
Leading companies operating in the Asia Pacificbioreactors market are Thermo Fisher Scientific Inc, General Electric Company, GEA Group, PBS Biotech, Inc,and MERCK KGaA, among others.
Asia PacificBioreactors Market, By Country, 2019 (%)
The report segments Asia Pacificbioreactorsmarketas follows:
Asia PacificBioreactors Market– ByCell
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
- Others
Asia PacificBioreactors Market– ByMolecule
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Stem Cells
- Gene Therapy
- Others
Asia Pacific Bioreactors Market – ByTechnology
- Wave-Induced Motion SUB
- Stirred SUB
- Single-Use Bubble Column
- Others
Asia PacificBioreactors Market – By End User
- Biopharma Manufacturers
- Research and Development Organizations
- Contract Manufacturing Organizations (CMOs)
Asia PacificBioreactors Market– By Country
- China
- Japan
- India
- South Korea
- Australia
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com